Pro Trade: PILL
Direxion Daily Pharmaceutical & Medical Bull 3X
22/4 update: PILL is now up 10% and looks to have further to run.


Direxion Daily Pharmaceutical & Medical Bull 3X
22/4 update: PILL is now up 10% and looks to have further to run.



JD.COM is approaching a price level where we expect buying interest to pick up. Watch for an initial turn higher in the stochastic

Alibaba should find buying support between $85.50 and $88.

Brambles is among the best-performing stocks in our ASX top 20 model, after increasing 25.4% since being added on 3/10/22.
BXB delivered 3Q23 YTD sales growth (constant currency) of 15%.

CSCO:NAS is now under Algo Engine buy conditions and investors should consider accumulating a position within the $43 – $47 price range.

19/4 update: New Inner Circle video
The Lottery Corporation is now under Algo Engine buy signals.

In case you missed it, you can watch last night’s webinar here.
Raytheon Technologies Corporation Common remains our preferred overweight exposure heading into first-quarter results. RTX reports on April 25, 2023.

January 24, 2023: Raytheon Technologies reported fourth-quarter sales of $18.1 billion, up 6 percent over the prior year. GAAP EPS from continuing operations of $0.96 was up 109 percent versus the prior year and included $0.31 of acquisition accounting adjustments and net significant and/or non-recurring charges. Adjusted EPS of $1.27 was up 18 percent versus the prior year. Both GAAP and Adjusted EPS included about 6 cents of a tax benefit associated with legal entity and operational reorganizations.
The company recorded net income from continuing operations attributable to common shareowners in the fourth quarter of $1.4 billion, up 108 percent versus the prior year which included $446 million of acquisition accounting adjustments and net significant and/or non-recurring charges. Adjusted net income was $1.9 billion, up 16 percent versus prior year. Operating cash flow from continuing operations in the fourth quarter was $4.6 billion. Capital expenditures were $855 million, resulting in free cash flow of $3.8 billion
Or start a free thirty day trial for our full service, which includes our ASX Research.